Cardio Diagnostics (CDIO) vs Intellia Therapeutics (NTLA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Intellia Therapeutics is the larger company by market cap ($1.71 billion vs $5.7 million), about 299.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CDIO | NTLA |
|---|---|---|
| Share price | $1.93 | $12.19 |
| Market cap | $5.71M | $1.71B |
| 1-day change | -2.03% | +4.10% |
| YTD return | — | +30.26% |
| 1-year return | — | -42.71% |
| 5-year return | — | -91.03% |
| EPS (TTM) | $-2.91 | $-3.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.91 | $28.25 |
| 52-week low | $0.97 | $7.95 |
| Distance from 52-week high | -75.60% | -56.85% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +89.58% |
| Average volume | 55.63K | 4.16M |
| Shares outstanding | 2.96M | 140.13M |
| Employees | — | 377 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Intellia Therapeutics is about 299.1 times larger than Cardio Diagnostics by market value ($1.71B vs $5.71M).
About Intellia Therapeutics
NTLA stock →Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 377 employees
CDIO vs NTLA FAQ
Which is bigger, Cardio Diagnostics or Intellia Therapeutics?
Intellia Therapeutics (NTLA) is larger, with a market capitalization of $1.71B compared with $5.71M for Cardio Diagnostics (CDIO).
Are Cardio Diagnostics and Intellia Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.